A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of Iluvien(R) in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsensive to Available Therapies (Respond)
AuthID
P-00M-MTJ
P-00M-MTJ